Inventor · disambiguated record
Paymaan Jafar-Nejad
Also filed as: JAFAR-NEJAD PAYMAAN
4 granted patents·12 pending applications·4 citations·filing 2019–2025
65Inventor score
Files withIONIS PHARMACEUTICALS INC16
Top patents by PatentIndex Score
16 records- 0190US11261446B2Compounds and methods for modulating UBE3A-ATSIONIS PHARMACEUTICALS INC·Filed 2021·Granted Mar 1, 2022·3 cites·17 claims
- 0283US2025283081A1Compounds and Methods for Modulating UBE3A-ATSIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0380US2024401039A1Compounds and Methods for Reducing ATXN2 ExpressionIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0479US12227746B2Compounds and methods for modulating SCN2AIONIS PHARMACEUTICALS INC·Filed 2023·Granted Feb 18, 2025·0 cites·26 claims
- 0577US11078486B2Compounds and methods for reducing ATXN2 expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted Aug 3, 2021·1 cites·36 claims
- 0674US2024287513A1Compounds and Methods for Modulating Splicing of Pre-MRNAIONIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0772US12129466B2Compounds and methods for modulating UBE3A-ATSIONIS PHARMACEUTICALS INC·Filed 2022·Granted Oct 29, 2024·0 cites·19 claims
- 0870US2024026353A1Compounds and methods for modulating scn2aIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0968US2025270556A1Compounds and methods for modulating scn2aIONIS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1064US2025109396A1Compounds and methods for modulating progranulin expressionIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1162US2024360449A1Compounds and methods for modulating scn1a expressionIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1262US2023117089A1Compounds and methods for modulating splicing of pre-mrnaIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1359US2024336915A1Compounds and methods for reducing dux4 expressionIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1455US2023124616A1Compounds and methods for modulating kcnq2IONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1553US2023043648A1Compounds and methods for modulating scn1a expressionIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1653US2024229042A1Compounds and methods for reducing kcnt1 expressionIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paymaan Jafar-Nejad files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →